Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03745794 · ClinicalTrials.gov registry record · Phase 2
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 136
- Enrollment target
NCT03745794: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT03745794 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03745794, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 136 participants
- Enrollment target
Study Summary
This phase II trial studies how an additional anesthetic nerve block, called a quadratus lumborum block, works to reduce the need for opioids in patients after pancreatic surgery. Giving an additional regional anesthetic after surgery may hasten the weaning process, reduce the need for opioid medications upon discharge, and reduce the risk of opioid dependence.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- DRUG Quadratus Lumborum Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2025-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03745794
The ClinicalTrials.gov registry entry for NCT03745794 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03745794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03745794 about?
NCT03745794 is a clinical study titled "Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery". This phase II trial studies how an additional anesthetic nerve block, called a quadratus lumborum block, works to reduce the need for opioids in patients after pancreatic surgery. Giving an additional regional anesthetic after surgery may hasten the weaning process, reduce the need for opioid medica...
What is the current status of trial NCT03745794?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 136 participants. The study started on 2019-02-28. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT03745794?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Quadratus Lumborum Block (DRUG).
Who is sponsoring clinical trial NCT03745794?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.